{"id":624531,"title":"Notice: Revision of Guidance documents: Conduct and Analysis of Comparative Bioavailability Studies & Comparative Bioavailability Standards: Formulations used for Systemic Effects - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-27","captureTimestamp":"2026-02-27T02:32:49.211000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/comparative-bio-formulations-notice.html","snippet":"Notice: Revision of Guidance documents: Conduct and Analysis of Comparative Bioavailability Studies & Comparative Bioavailability Standards: Formulations used for Systemic Effects June 8, 2018 Our file number: 18-104623-884 Health Canada is pleased to announce the revision of two…","rawSnapshotUrl":"/api/snapshots/raw/624531","browseUrl":"https://replay.healtharchive.ca/job-6/20260227023249/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/comparative-bio-formulations-notice.html#ha_snapshot=624531","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}